SPI Earns Silver Medal in EcoVadis Sustainability Assessment

Summit Pharmaceuticals International Corporation (headquartered in Chiyoda-ku, Tokyo; Katsuya Okuyama, President & CEO; hereinafter “SPI”) has been awarded a Silver Medal (within the top 15%) in the 2024 Sustainability Assessment provided by EcoVadis.

EcoVadis is an international organization that evaluates sustainability performances of more than 130,000 companies in 180 countries and their supply chains using its unique platform in four categories: environment, labor and human rights, ethics, and sustainable procurement.

To contribute to the realization of a sustainable society, SPI solves social issues through its business activities and engages in ongoing sustainability promotion activities.

About EcoVadis: https://ecovadis.com/

[Contact]
Summit Pharmaceuticals International Corporation
Business Administration Dept. Corporate Planning Group
Tel：+81-3-5220-1500
Email：2b-b@summitpharma.co.jp